Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2024 Dec 2;79(12):3332-3339.
doi: 10.1093/jac/dkae369.

Ceftriaxone-resistant Neisseria gonorrhoeae detected in England, 2015-24: an observational analysis

Affiliations
Observational Study

Ceftriaxone-resistant Neisseria gonorrhoeae detected in England, 2015-24: an observational analysis

Helen Fifer et al. J Antimicrob Chemother. .

Abstract

Objectives: Since June 2022, there has been a rise in the number of ceftriaxone-resistant Neisseria gonorrhoeae cases detected in England (n = 15), of which a third were XDR. We describe the demographic and clinical details of the recent cases and investigate the phenotypic and molecular characteristics of the isolates. For a comprehensive overview, we also reviewed 16 ceftriaxone-resistant cases previously identified in England since December 2015 and performed a global genomic comparison of all publicly available ceftriaxone-resistant N. gonorrhoeae strains with mosaic penA alleles.

Methods: All N. gonorrhoeae isolates resistant to ceftriaxone (MIC > 0.125 mg/L) were whole-genome sequenced and compared with 142 global sequences of ceftriaxone-resistant N. gonorrhoeae. Demographic, behavioural and clinical data were collected.

Results: All cases were heterosexual, and most infections were associated with travel from the Asia-Pacific region. However, some had not travelled outside England within the previous few months. There were no ceftriaxone genital treatment failures, but three of five pharyngeal infections and the only rectal infection failed treatment. The isolates represented 13 different MLST STs, and most had the mosaic penA-60.001 allele. The global genomes clustered into eight major phylogroups, with regional associations. All XDR isolates belonged to the same phylogroup, represented by MLST ST16406.

Conclusions: Most cases of ceftriaxone-resistant N. gonorrhoeae detected in England were associated with travel from the Asia-Pacific region. All genital infections were successfully treated with ceftriaxone, but there were extragenital treatment failures. Ceftriaxone resistance continues to be associated with the penA-60.001 allele within multiple genetic backgrounds and with widespread dissemination in the Asia-Pacific region.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Phylogeny of 171 ceftriaxone-resistant N. gonorrhoeae with mosaic penA alleles, detected globally. This figure appears in colour in the online version of JAC and in black and white in the print version of JAC.

References

    1. UK Health Security Agency . Sexually transmitted infections and screening for chlamydia in England, 2023. 2024. https://www.gov.uk/government/statistics/sexually-transmitted-infections...
    1. Jensen JS, Unemo M. Antimicrobial treatment and resistance in sexually transmitted bacterial infections. Nat Rev Microbiol 2024; 22: 435–50. 10.1038/s41579-024-01023-3 - DOI - PubMed
    1. Sánchez-Busó L, Yeats CA, Taylor Bet al. . A community-driven resource for genomic epidemiology and antimicrobial resistance prediction of Neisseria gonorrhoeae at Pathogenwatch. Genome Med 2021; 13: 61. 10.1186/s13073-021-00858-2 - DOI - PMC - PubMed
    1. Ohnishi M, Golparian D, Shimuta Ket al. . Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: Detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob Agents Chemother 2011; 55: 3538–45. 10.1128/AAC.00325-11 - DOI - PMC - PubMed
    1. Unemo M, Golparian D, Nicholas Ret al. . High-level cefixime- and ceftriaxone-resistant N. gonorrhoeae in Europe (France): novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob Agents Chemother 2012; 56: 1273–80. 10.1128/AAC.05760-11 - DOI - PMC - PubMed

Publication types

MeSH terms

Associated data

LinkOut - more resources